The drug major continues to see healthy demand across key markets, with US and Europe businesses performing in line with ...
Aurobindo Pharma reported September quarter consolidated net profit rose nearly 4% to ₹848 crore compared with ₹817 crore a ...
Aurobindo Pharma net profit up only by 3.8% to Rs. 848 crore in Q2: Our Bureau, Mumbai Friday, November 7, 2025, 12:50 Hrs [IST] Aurobindo Pharma, a second largest Indian pharma c ...
Hyderabad-based pharmaceutical giant Aurobindo Pharma Limited has reported a 4 percent jumpin consolidated net profit to Rs ...
Aurobindo Pharma reports Q2 net profit of Rs 848 crore, a 4% increase, driven by strong US and Europe sales. Revenue rises to Rs 8,286 crore.
Aurobindo Pharma reported a 4% increase in net profit to Rs 848 crore for Q2, driven by strong sales in the US and Europe.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results